Long-term incidence and risk of noncardiovascular and all-cause mortality in apparently healthy cats and cats with preclinical hypertrophic cardiomyopathy.
Phillip R FoxBruce W KeeneKenneth LambKarsten E SchoberValérie ChetboulVirginia Luis FuentesJessie Rose PayneGerhard WessDaniel F HoganJonathan A AbbottJens HäggströmGeoffrey CulshawDeborah Fine-FerreiraEtienne CoteEmilie Trehiou-SechiAlison A Motsinger-ReifReid K NakamuraManreet SinghWendy A WareSabine C RiesenMichele BorgarelliJohn E RushAndrea VollmarMichael B LesserNicole Van IsraelPamela Ming-Show LeeBarret BulmerRoberto SantilliMaribeth J BossbalyNadine QuickClaudio BussadoriJanice BrightAmara H EstradaDan G OhadMaria Josefa Fernández Del PalacioJennifer Lunney BrayleyDenise S SchwartzSonya G GordonSeung Woo JungChristina M BovePaola G BrambillaN Sydney MoïseChristopher StauthammerCecilia QuintavallaFerenc ManczurRebecca L StepienCarmel MooneyYong-Wei HungRemo LobettiAlice TamboriniMark A OyamaAndrey KomolovYoko FujiiRomain PariautMasami UechiVictoria Yukie Tachika OharaPublished in: Journal of veterinary internal medicine (2019)
All-cause mortality was significantly greater in pHCM cats due to disease burden contributed by increased cardiovascular death superimposed upon noncardiovascular death.